Automated pupillometry and the Neurological Pupil index™ (NPi®) emerge as critical tools for assessing patients at risk of brain injury across a broad spectrum of diagnoses IRVINE, Calif.--(BUSINESS ...
IRVINE, Calif.--(BUSINESS WIRE)--A new peer-reviewed study shows that even one occurrence of an abnormal Neurological Pupil index™ (NPi®) differential, measured by NeurOptics’ NPi Pupillometer, can be ...
The presence of an abnormal NPi differential (a difference ≥ 0.7 between the right and left eye NPi values) is an important factor clinicians should consider in decision making when managing ...
NeurOptics Expands Globally, Launching NPi®-300 Automated Pupillometer in 15 International Countries
NPi-300 Pupillometer and the Neurological Pupil index™ (NPi®) represent the gold standard in automated pupillary assessment for patients at risk of brain injury NeurOptics, the worldwide leader in the ...
The NeurOptics NPi Pupillometer has been included in more than 120 clinical studies, adopted in over 650 hospitals in the U.S., and is represented in more than 35 countries worldwide. NeurOptics® is ...
NeurOptics, the worldwide leader in the science of pupillometry, today announced the U.S. launch of its NPi (R) -300, a next-generation automated pupillometer that enhances pupillary assessment to ...
Neuroptics Expands Globally, Launching Npi®-300 Automated Pupillometer In 15 International Countries
NeurOptics' NPi®-300, a next-generation pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, is now available globally in 15 countries. NPi-300 Pupillometer & the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback